Structural damage of chicken red blood cells exposed to platinum nanoparticles and cisplatin

Nanoscale Research Letters

Volumn 9, Issue 1, 2014, Pages

  Kutwin, Marta ^a   Sawosz, Ewa ^a   Jaworski, Sławomir ^a   Kurantowicz, Natalia ^a   Strojny, Barbara ^a   Chwalibog, André ^b  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cancer therapy; Cisplatin; Haemolysis; Platinum nanoparticles; Red blood cells

Indexed keywords

ANIMALS; CELLS; CYTOLOGY; DEFORMATION; DISEASES; NANOPARTICLES; PLATINUM; PLATINUM COMPOUNDS;

CANCER THERAPY; CIS-PLATIN; HAEMOLYSIS; PLATINUM NANO-PARTICLES; RED BLOOD CELL;

BLOOD;

DISCOIDAE;

EID: 84928400313     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-9-257     Document Type: Article

References (37)

1. Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G: Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.Anticancer Drugs 1998, 9:525–530.
2. Getaz EP, Beckley S, Fitzpatrick J, Dozier A: Cisplatin-induced hemolysis.N Engl J Med 1980, 302:334–335.
3. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ: Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague–Dawley rats.Inhal Toxicol 2008,20(6):575–583.
4. Kim D, El-Shall H, Dennis D, Morey T: Interaction of PLGA nanoparticles with human blood constituents.Colloids Surf B Biointerfaces 2005, 40:83–91.
5. Mocan T: Hemolysis as expression of nanoparticles-induced cytotoxicity in red blood cells.BMBN 2013, 1:7–12.
6. Mironava T, Simon M, Rafailovich MH, Rigas B: Platinum folate nanoparticles toxicity: cancer vs normal cells.Toxicol In Vitro 2013, 27:882–889.
7. Mohammadi H, Abedi A, Akbarzadeh A, Mokhtari MJ, Shahmabadi HE, Mehrabi MR, Javadian S, Chiani M: Evaluation of synthesized platinum nanoparticles on the MCF-7 and HepG-2 cancer cell lines.International Nano Letters 2013, 3:28.
8. Palmisano J, Agraharkar M, Kaplan AA: Successful treatment of cisplatin-induced hemolytic uremic syndrome with therapeutic plasma exchange.Am J Kidney Dis 1998, 32:314–317.
9. Gopal J, Hasan N, Manikandan M, Wu HF: Bacterial toxicity/compatibility of platinum nanospheres, nanocuboids and nanoflowers.Sci Rep 2013, 3:1260.
10. Asharani PV, Xinyi N, Hande MP, Valiyaveettil S: DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles.Nanomedicine 2010, 5:51–64.
11. Prasek M, Sawosz E, Jaworski S, Grodzik M, Ostaszewska T, Kamaszewski M, Wierzbicki M, Chwalibog A: Influence of nanoparticles of platinum on chicken embryo development and brain morphology.Nanoscale Res Lett 2013, 8:251.
12. Artelt S, Creutzenberg O, Kock H, Levsen K, Nachtigall D, Heinrich U, Rühle T, Schlögl R: Bioavailability of fine dispersed platinum as emitted from automotive catalytic converters: a model study.Sci Total Environ 1999, 228:219–242.
13. Xia XR, Monteiro-Riviere NA, Riviere JE: An index for characterization of nanomaterials in biological systems.Nat Nanotechnol 2010, 5:671–675.
14. Asharani PV, Sethu S, Vadukumpully S, Zhong S, Lim CT, Hande MP, Valiyaveettil S: Investigations on the structural damage in human erythrocytes exposed to silver, gold, and platinum nanoparticles.Adv Funct Mater 2010, 20:1233–1242.
15. Gehrke H, Pelka J, Hartinger CG, Blank H, Bleimund F, Schneider R, Gerthsen D, Bräse S, Crone M, Türk M, Marko D: Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations.Arch Toxicol 2011, 85:799–812.
16. Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE: Method for analysis of nanoparticle hemolytic properties in vitro.Nano Lett 2008, 8:2180–2187.
17. Shiny PJ, Mukherjee A, Chandrasekaran N: Haemocompatibility assessment of synthesised platinum nanoparticles and its implication in biology.Bioprocess Biosyst Eng 2014, 37:9911–9997.
18. Barshtein G, Arbell D, Yedgar S: Hemolytic effect of polymeric nanoparticles: role of albumin.IEEE Trans Nanobioscience 2011, 10:259–261.
19. 2) nanoparticles on human erythrocyte and lymphocyte cell in vitro.J Appl Toxicol 2013, 33:1097–1110.
20. Yildirim A, Ozgur E, Bayindir M: Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption.J Mater Chem B 2013,1(14):1909–1920.
21. Clark A, Zhu A, Sun K, Petty HR: Cerium oxide and platinum nanoparticles protect cells from oxidant-mediated apoptosis.J Nanopart Res 2011,13(10):5547–5555.
22. Standard practice for assessment of hemolytic properties of materials [http://www.astm.org]
23. Ribatti D: Chicken chorioallantoic membrane angiogenesis model.Methods Mol Biol 2012, 843:47–57.
24. Rashidi H, Sottile V: The chick embryo: hatching a model for contemporary biomedical research.Bioessays 2009, 31:459–465.
25. Yamagishi Y, Watari A, Hayata Y, Li X, Kondoh M, Yoshioka Y, Tsutsumi Y, Yagi K: Acute and chronic nephrotoxicity of platinum nanoparticles in mice.Nanoscale Res Lett 2013, 8:395.
26. Park EJ, Kim H, Kim Y, Park K: Intratracheal instillation of platinum nanoparticles may induce inflammatory responses in mice.Arch Pharm Res 2010, 33:727–735.
27. Dodge JT, Mitchell C, Hanahan DJ: The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.Arch Biochem Biophys 1963,100(1):119–130.
28. Rajeswaran A, Trojan A, Burnand B, Giannelli M: Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials.Lung Cancer 2008, 59:1–11.
29. Maloisel F, Kurtz JE, Andres E, Gorodetsky C, Dufour P, Oberling F: Platin salts-induced hemolytic anemia: cisplatin- and the first case of carboplatin-induced hemolysis.Anticancer Drugs 1995, 6:324–326.
30. McWhinney SR, Goldberg RM, McLeod HL: Platinum neurotoxicity pharmacogenetics.Mol Cancer Ther 2009, 8:10–16.
31. Mekid H, Tounekti O, Spatz A, Cemazar M, Kebir F, Mir L: In vivo evolution of tumour cells after the generation of double-strand DNA breaks.Br J Cancer 2003, 88:1763–1771.
32. Weiss DJ, Kristensen A, Papenfuss N: Quantitative evaluation of irregularly spiculated red blood cells in the dog.Vet Clin Pathol 1993, 22:117–121.
33. Swanepoel AC, Pretorius E: Scanning electron microscopy analysis of erythrocytes in thromboembolic ischemic stroke.Int J Lab Hematol 2012, 34:185–191.
34. Clowes AW, Reidy MA, Clowes MM: Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in absence of endothelium.Lab Invest 1983, 49:327–333.
35. Marmur J, Doty P: Determination of the base composition of deoxyribonucleic acid from its thermal denaturation temperature.J Mol Biol 1962, 5:109–118.
36. Jung Y, Lippard SJ: Direct cellular responses to platinum-induced DNA damage.Chem Rev 2007, 107:1387–1407.
37. Porcel E, Liehn S, Remita H, Usami N, Kobayashi K, Furusawa Y, Le Sech C, Lacombe S: Platinum nanoparticles: a promising material for future cancer therapy?Nanotechnology 2010, 21:085103.